RESEARCH & SCIENCE
2023 Ocular Melanoma Awardees
Daniel Kim - Medical Student Awardee Institution: Harvard Medical School Area of Research: “Real-world efficacy and clinical predictors of immunotherapy response among Veteran uveal melanoma patients”
Emily Gordon - Medical Student Awardee Institution: Columbia University Vagelos College of Physicians and Surgeons Area of Research: “Using Circulating Tumor DNA and Exosomes to Predict Clinical Outcomes in Patients with Metastatic Uveal Melanoma Receiving Systemic Immunotherapy or Liver-Directed Immunoembolization” Arina Nisanova - Medical Student Awardee Institution: University of California Davis Area of Research: “Risk Factor Analysis of Young Patients with Uveal Melanoma Treated with Proton Beam Therapy”
Xiaonan Xu, MD, PhD - Career Development Awardee Institution: H. Lee Moffitt Cancer Center & Research Institute Area of Research: “Understand metastasis of uveal melanoma in vivo via novel mouse models”
THE VISION PLATFORM Launched in May 2021, the VISION Platform (VISION) is in its 3rd year of recruitment with over 450 registered participants. VISION’s power is elevating the patient perspective by collecting patient-reported data. Working with an interdisciplinary and inter-institutional steering committee with patients and caregivers at its core, the VISION team published data from the first year of the VISION Registry in the 2022 VISION Data Report which can be accessed below. Updated data and new data will be provided in the 2023 VISION Registry Data Report expected to be published in the fall. The VISION team is currently working with partners and stakeholders to incorporate VISION into ongoing clinical trials. Additionally, VISION continues to work with its Steering Committee to incorporate patients' feedback and develop and implement new features to meet the needs of the ocular melanoma community.
Our international partners are actively helping to promote and recruit patient participants to VISION. By increasing global participation, VISION will be able to highlight regional trends, similarities and differences. OUR PARTNERS
2022 VISION Data Report at https://online.flippingbook.com/view/691627414/
Check out these NEW features!
Private and Safe OM Patient and Caregiver Discussion Forum VISION Clinical Trial Connector Tool Newly Established VISION Features:
Made with FlippingBook Ebook Creator